OA07358A - Polyméthylène-imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant. - Google Patents

Polyméthylène-imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.

Info

Publication number
OA07358A
OA07358A OA57957A OA57957A OA07358A OA 07358 A OA07358 A OA 07358A OA 57957 A OA57957 A OA 57957A OA 57957 A OA57957 A OA 57957A OA 07358 A OA07358 A OA 07358A
Authority
OA
OAPI
Prior art keywords
alkyl
hydrogen
chlorine
fluorine
optionally substituted
Prior art date
Application number
OA57957A
Other languages
English (en)
French (fr)
Inventor
Gilbert Regnier
Alain Dhainaut
Michel Laubie
Jacques Duhamel
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of OA07358A publication Critical patent/OA07358A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA57957A 1982-03-30 1983-03-30 Polyméthylène-imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant. OA07358A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8205373A FR2524467A1 (fr) 1982-03-30 1982-03-30 Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
OA07358A true OA07358A (fr) 1984-08-31

Family

ID=9272531

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57957A OA07358A (fr) 1982-03-30 1983-03-30 Polyméthylène-imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.

Country Status (14)

Country Link
US (1) US4514398A (da)
EP (1) EP0090733B1 (da)
JP (1) JPS58180482A (da)
AT (1) ATE16286T1 (da)
AU (1) AU559376B2 (da)
CA (1) CA1206150A (da)
DE (1) DE3361100D1 (da)
ES (1) ES8405273A1 (da)
FR (1) FR2524467A1 (da)
IE (1) IE55223B1 (da)
NZ (1) NZ203724A (da)
OA (1) OA07358A (da)
PT (1) PT76470B (da)
ZA (1) ZA832214B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58128002A (ja) * 1982-01-25 1983-07-30 Sony Corp 記録再生装置
FR2544315B1 (fr) * 1983-04-12 1985-07-05 Adir Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
US5243047A (en) * 1988-02-15 1993-09-07 Imperial Chemical Industries Plc Triazole/thiazole amino-s-triazine bonding agents
JP2614921B2 (ja) * 1989-07-05 1997-05-28 帝人株式会社 ２，４，６―三置換―ｓ―トリアジン誘導体，及びその製造方法
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB8929022D0 (en) * 1989-12-22 1990-02-28 Ici Plc Diazine derivatives
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
FR2664594B1 (fr) * 1990-07-11 1992-09-18 Adir Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2667243B1 (fr) * 1990-09-27 1994-11-04 Adir Utilisation de s derives de la triazine et de la pyrimidine pour l'obtention de medicaments reversant la resistance aux agents anticancereux et antimalariques.
FR2673627B1 (fr) * 1991-03-07 1993-05-07 Adir Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
JPH07506084A (ja) * 1991-11-12 1995-07-06 ファイザー　インク． 抗腫瘍活性増強用のトリアジン誘導体
PT650476E (pt) * 1993-04-07 2002-11-29 Otsuka Pharma Co Ltd Agente vasodilatador periferico que contem derivados n-acilados de 4-amino-piperidina como ingredientes activos
WO1997040010A1 (en) * 1996-04-24 1997-10-30 Emory University Halogenated naphthyl methoxy piperidines for mapping serotonin transporter sites
US6943161B2 (en) * 1999-12-28 2005-09-13 Pharmacopela Drug Discovery, Inc. Pyrimidine and triazine kinase inhibitors
MY142362A (en) * 2004-01-29 2010-11-30 Otsuka Pharma Co Ltd Pharmaceutical composition for promoting angiogenesis
WO2012054978A1 (en) 2010-10-27 2012-05-03 Ludwig Institute For Cancer Research Limited Novel anti-cancer agents
EP3085701B1 (en) * 2013-12-20 2019-02-20 Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China N, n' substituted piperidinamine compounds, and preparation method and usage thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL277028A (da) * 1961-04-19
US3362221A (en) * 1964-06-30 1968-01-09 Hays Corp Magnetic flow transmitter system
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3576805A (en) * 1969-05-22 1971-04-27 American Cyanamid Co N**2,n**4,n**6-trisubstituted melamines

Also Published As

Publication number Publication date
PT76470B (fr) 1986-03-11
AU559376B2 (en) 1987-03-05
JPS58180482A (ja) 1983-10-21
AU1296783A (en) 1983-10-06
IE55223B1 (en) 1990-07-04
EP0090733B1 (fr) 1985-10-30
PT76470A (fr) 1983-04-01
ES521191A0 (es) 1984-06-01
ATE16286T1 (de) 1985-11-15
IE830696L (en) 1983-09-30
CA1206150A (fr) 1986-06-17
US4514398A (en) 1985-04-30
ES8405273A1 (es) 1984-06-01
NZ203724A (en) 1985-12-13
DE3361100D1 (en) 1985-12-05
FR2524467B1 (da) 1984-05-11
EP0090733A1 (fr) 1983-10-05
FR2524467A1 (fr) 1983-10-07
ZA832214B (en) 1983-12-28

Similar Documents

Publication Publication Date Title
OA07358A (fr) Polyméthylène-imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
OA07934A (fr) Nouveaux dérivés de la xanthine, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
DE3362022D1 (en) Xanthine derivatives, process for their preparation and pharmaceutical compositions containing them
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2680507B1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2703051B1 (fr) Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
OA07400A (fr) Polyméthylène diamiques, N,N'-subtituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
OA07536A (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
DK0531419T3 (da) Bistriazener som kemoterapeutiske midler
OA07703A (fr) Polyméthylène imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
NO20001541L (no) Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
DK0434560T3 (da) Hidtil ukendte substituerede aminosyrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ATE20360T1 (de) Polysaccharidsubstanz, verfahren zu deren herstellung, dieselbe enthaltende pharmazeutische zusammensetzungen sowie deren verwendung als medikamente.